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Abstract
Despite certain achievements in lung cancer treatment, the essential number of patients is subjected to palliative and symp-
tomatic treatment. Hemoptysis addition is the one of most heavy symptoms of unresectable lung cancer. No less heavy complication 
is an atelectasis and hypoventilation of a lobe or a whole lung, which clinical image is attended by respiratory failure phenomena or 
association of purulent-septic pneumonia. The combination of endoscopic hemostasis with roentgen endovascular embolization of 
bronchial arteries (REEBA) allows to increase patients’ live quality and to prolong it for some time. 
In the clinic REEBA has been done in 121 patients with unresectable forms of lung cancer. The causes of surgical treatment 
refusal were a widespread tumor process, age, and severity of associated pathology. 
Hemostasis was achieved in 112 patients. A relapse of pulmonary bleeding was observed in 11 patients, who underwent the 
repeated REEBA. Lethal outcome was observed in 5 cases. Hemostasis was ineffective in 9 patients. 
Thus, the experience of using REEBA and endoscopic hemostasis at complicated forms of unresectable lung cancer allows to 
increase the life quality and in further to realize chemoradial therapy that gives a possibility to prolong a patient’s life. 
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1. Introduction
The urgency of the problem of lung cancer is connected with the growth of morbidity, high 
lethality and bad treatment results. Lung cancer occupies the first place among men in Ukraine, and 
it remains a leader among causes of death from malignant tumors. 
Despite certain achievements in lung cancer treatment, the essential number of patients is 
subjected to palliative and symptomatic treatment. The hidden course of a tumor process and long 
absence of evident clinical manifestations mainly determine great complications of the modern 
lung cancer diagnostics. The experience shows that most patients with firstly diagnosed diseases 
visit a doctor at already widespread tumor process that doesn’t allow the radical treatment. The 
presence of severe complication of the tumor process in them doesn’t allow to apply chemotherapy 
or radial therapy. Thus, among patients, admitted at stationary treatment in different oncological 
and surgical medical institutions, ІІІ and IV stages of disease are established in 40–75 %, at that 
IV stage – in 12 % [1, 2]. At the same time the presence of concomitant pathology and old age don’t 
give a possibility to realize the radical surgical intervention at the absence of inoperability signs. 
 An addition of hemoptysis or pulmonary bleeding is the one of most complicating symp-
toms of cancer inoperability [3]. A bleeding at lung cancer as an initial symptom of disease is de-
tected in 20 % of patients and at the final stage of disease a bleeding appears in 60 % of patients [4]. 
Lung cancer causes pulmonary bleeding in the period of necrosis and destruction of a bronchus 
wall. As a result of malignant process there takes place a break of newly created thin-walled lacuna 
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and the net of small vessels that don’t have an elastic coat [5]. Thus, a bleeding at lung cancer indi-
cates an essential lesion of big bronchi or necrotic changes of a lung parenchyma. 
 No less dangerous complication is an atelectasis and hypoventilation of a lobe or a whole 
lung, which clinical image is attended by respiratory failure phenomena or association of puru-
lent-septic pneumonia [6].
An important role in the pathogenesis of pulmonary bleeding is played by an arrosion of a 
vessel by a tumor, break of vascular wall, blood access in alveoli from bronchial arteries. 
Last time the methods of endoscopic recanalization of tumor stenosis and hemostasis of 
a bleeding tumor using a laser radiation, plasma flows, electrocoagulation at treating complicat-
ed forms of lung cancer appeared [7]. Roentgen endovascular embolization of bronchial arteries 
(REEBA) is used for these aims more seldom [8] and the method of radiofrequency thermoabla-
tion of a tumor bronchus stenosis (RFA) is practically not used [9]. The method of radiofrequency 
ablation was used for the first time for a liver tumors ablation. The first experimental works were 
published in 80 years of 20 century [10]. RFA method is realized by introduction of the special at-
raumatic electrode in a tumor and influence of current with the frequency 450–500 kHz on it. As a 
result the tumor tissue is heated to the temperature 60–90 °С that conditions irreversible processes 
in cells. A tumor is necrotized [11].
The offered method of endobronchial RFA using the electrode, elaborated by us, is very 
effective in the treatment of tumor stenosis of bronchi and trachea. 
The introduction of such non-standard technologies as REEBA and endoscopic recanali-
zation of a tumor stenosis of respiratory tracts, RFA of tumors allowed to provide conditions for 
giving help to patients [12].
At this message we want to share own experience of using endovascular and endoscopic 
methods in the treatment of lung cancer complicated forms. 
2. Aim of research
The aim of research was in elaboration of the complex method of palliative treatment of 
patients with the central lung cancer, complicated by hemoptysis and tumor bronchus stenosis. The 
use of this method allows to improve not only patients’ life quality by its term also. 
3. Materials and methods
In the clinic REEBA with bronchoscopic recanalization and hemostasis has been done in 
121 patients with unresectable forms of lung cancer, complicated by hemoptysis, pulmonary bleed-
ing, atelectasis of a central or lobe bronchus. The analyzed group included 84 men and 37 women. 
Patients’ distribution by stages was the following: ІІІа – 25, ІІІб – 58, ІV – 38. The causes of sur-
gical treatment refusal were a widespread tumor process, age and severe associated pathology and 
often these both causes. Among associated pathologies the main ones were: myocardium infarction 
in an anamnesis, complicated by postinfarction cardiosclerosis, heart rate disorders, disorders of 
cerebral blood circulation, respiratory or heart failure, COLD. Three patients have been previously 
operated in different medical institutions because of the central lung cancer. In two cases the cause 
of a bleeding is a tumor relapse in bronchial stump. 74 patients had an ordinary hemoptysis and 
little pulmonary bleeding, attended by blood secretion in volume up to 100 ml a day. The expressed 
pulmonary bleeding was observed 47 patients and was 200–400 ml a day. 
REEBA was realized on the apparatus Аllara Xper FD – 20 “Phillips”. After catherization 
of a femoral artery according to Seldinger, the catheter “Cobra” 5F2 was inserted in the thoracic 
aorta. Two patients underwent catherization of the right radial artery because of Leriche syndrome 
in their anamnesis. Then the angiography with catherization and contrasting of bronchial arteries 
on the side of injury was realized. After revelation and catherization of bronchial arteries that 
nourish the tumor, the working catheter was inserted in it by “Transend” conductor. It was used for 
vessels embolization by “Italamp” emboli with sizes 420–750 mm. The criterion of embolization 
effectiveness was an absence of bronchial arteries contrasting in the tumor zone [13]. 
According to the literary data, the most frequent complications at REEBA realization were: 
myelitis, appeared as a result of emboli hitting the spinal vessels that anastomosed with bronchial 
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arteries and a pain syndrome, connected with ischemia due to bronchial arteries embolization. 
Such complication as myelitis was not observed in our research, because we always inserted the 
catheter in bronchial arteries selectively. A pain syndrome was observed in almost all patients, but 
it was stopped by ordinary analgesics and was not long. 
The methods of endoscopic RFA coagulation and recanalization of a tumor using the bron-
choscope were the following. In almost all cases we used a local anesthesia and 2-channel fibro-
bronchoscopes “Olympus” and “Pentax”. In 3 patients, who underwent fibrobronchoscopies under 
local anesthesia very badly, we used a general anesthesia. They underwent the rigid bronchoscopy 
using Fridel bronchoscope with inserted fibrobronchoscope with the mono-polar electrode. Lido-
caine 2 % – 20,0 was used as a local anesthetic. After the assiduous anesthesia of respiratory tracts, 
the thin electrode was conducted to the tumor through the working channel of bronchoscope. For 
these aims at the beginning there was used the electrode for cardioablation, connected to the ap-
paratus FОТЕК 150. In most cases of operative interventions we used the mono-polar electrode, 
elaborated by us, that allowed to decrease the number of interventions from 4–5 to 2–3. The work-
ing characteristics of FОТЕК 150 are: capacity 30 Watt, exposition time 20–30 seconds. The effec-
tiveness criterion was a bronchus recanalization. In cases, when we used endobronchial RFA under 
local anesthesia, all patients were active immediately after finishing the operative intervention. In 
cases, when we used general anesthesia, patients needed observation during 2–3 hours.
4. Results of research
As a result of REEBA and endoscopic recanalization we succeeded in stopping a bleeding 
and hemoptosis in 112 (92,5 %) patients. Hemostasis was ineffective in 9 (7,5 %) patients. The 
causes were in an impossibility to realize the embolization of vessels that nourish a tumor because 
of anatomic features of vessels, anamostoses between the small and large circle of lung blood sup-
ply. At the same time the important role was played by the complication in endoscopic coagulation 
of a tumor surface at upper lobe localization. A lethal result of the long bleeding was observed in 
5 cases. The acute myocardium infarction appeared in 1 patient with a hollow form of lung cancer 
in early postoperative period, in other 4 cases the cause of lethal result was the long bleeding from 
the breaking tumor, and a source of this long bleeding were vessels of the small circle of blood cir-
culation. In 5 cases we succeeded in radical operative interventions after REEBA, endobronchial 
RFA and radial therapy. We realized one pneumonectomy and four lobectomies. 
Until the present time there are no doubts about REEBA effectiveness in the treatment of 
pulmonary bleedings, even massive ones [13]. At the lung cancer a bleeding of massive type is 
seldom that allows to use REEBA successively for its stop [14]. At an angiography at REEBA there 
was revealed the widened and deformed vascular net in the tumor zone, endovazation of contrast, 
widening of arteries with a pathological bypassing. 
REEBA was considered effective at the complete absence of contrasting of arteries that take 
part in tumor blood supply [15]. REEBA must not be realized at wide pathologic anamostoses that 
make this procedure dangerous that is proved by other authors [16]. The absolute contraindication 
for REEBA is anamostoses with spinal, vertebral and neck arteries. 
The stop of bleeding allowed us to realize the chemoradial treatment of 93 patients. The rest 
28 did not undergo the chemoradial therapy because of a heavy concomitant pathology, continuous 
bleeding or low functional rates. Bleeding relapses were observed in 11 patients, the causes were 
in the further growth of cancer tumor and its continuous disintegration. The period of observation 
over patients was 10 months. 
5. Discussion of results
The experience of endoscopic hemostasis at the lung cancer demonstrated the effectiveness 
of this method at unessential bleedings and hemoptysis. Massive blood supply in respiratory tracts 
doesn’t allow to control a tumor coagulation process and makes this method ineffective [17].
The use of endobronchial RFA method allowed to attain the good effect of recanalization 
and coagulation. But at more intensive pulmonary bleedings this method of hemostasis is not effec-
tive. Previously at using diathermocoagulation for ceranalization of tumor stenoses, the pulmonary 
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bleeding in 10 % of patients not only did not stop but intensified. Our experience testifies that annu-
ally at realization of diathermocoagulative recanalization of bronchial and tracheal tumor stenoses 
we had 1–2 lethal cases, connected with an intense pulmonary bleeding and asphyxia of patients. 
In the aforesaid connection all patients underwent REEBA for the prophylaxis of pulmonary 
bleeding at endobronchial recanalization. It allowed not only stop the pulmonary bleeding but also 
decelerate the tumor growth by closing the main vessel of its blood supply. 
All aforesaid allowed us to elaborate the method of combined hemostasis at lung cancer. At 
the beginning patients underwent REEBA then the endoscopic hemostasis method was used. The 
separate use of endoscopic hemostasis is possible at central forms of lung cancer, when the bleed-
ing tumor is localized in main or lobe bronchi. At injuring more peripheral parts of bronchial tree, 
especially at hollow cancer forms, REEA was the single treating method, because of absence of the 
tumor stenosis and atelectasis of the main or lobe bronchus [18].
According to the data of several authors, the mean life duration after endoscopic recanali-
zation of tumor stenoses, caused by a malignant process, doesn’t exceed 4,5 moths [19]. Due to the 
offered method we not only improved patient’s live quality but also prolonged it up to 10 months. 
At the same time the use of embolization and radiofrequency ablation allowed in several cases to 
realize the course and radio- or chemotherapy that also allowed to prolong patients’ life [20]. In 
several cases we realized REEBA repeatedly in the little number of patients. It was connected with 
the hemoptysis relapse. On the control angiogram we saw that the tumor is supplied with blood due 
to collateral branches of intercostal arteries, placed upper and lower than the tumor. Tumor sizes in 
all cases were essentially less than at the beginning of treatment. In such cases we realized embo-
lization of intercostal arteries, which supplied the tumor with blood. 
At control fibrobronchoscopies on 3–4th day we observed the started tumor necrosis. More 
often the purulent endobronchitis with secretion of the great amount of purulent sputum appeared 
in patients on 5th day. At the same time the temperature rise was observed in many patients, intoxi-
cation symptoms appeared. In this connection we realized the symptomatic, anti-inflammatory and 
antibacterial therapy before endobronchial RFA. After improving a patient’s state, approximately 
on 2–3th week, we stated the radio- or chemotherapy. 
Last time bronchoscopes appeared on the base of the clinic of Odessa national medical uni-
versity and Odessa Regional oncologic dispensary that allowed not only to realize RFA of bronchial 
tumors effectively, but also to make endophotos that testify to the effectiveness of the offered method.
At injuring more peripheral parts of bronchial tree, especially at hollow lung cancer forms, 
REEBA was the single treating method that allowed not only to stop a bleeding but also to decrease 
a speed of tumor growth. Thus, the experience of REEBA and endoscopic hemostasis use at com-
plicated unresectable forms of lung cancer allows to make the following conclusions. 
6. Conclusions
1. REEBA is a main way of hemostasis at complicated lung cancer forms. At central forms 
of lung cancer, complicated by bleedings and bronchus atelectasis, it is expedient to combine REE-
BA with endoscopic laser, electrocoagulation, RFTA of a tumor. 
2. The use of radiofrequency thermoablation method for eliminating bronchial atelectasis 
needs further clinical studies. 
3. The expedience of the aforesaid methods as a stage of preparation for chemoradiotherapy 
needs a further study. 
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